These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1003730)

  • 1. Factors in the dialysis regimen which contribute to alterations in the abnormalities of uremia.
    Lowrie EG; Steinberg SM; Galen MA; Gagneux SA; Lazarus JM; Gottlieb MN; Merrill JP
    Kidney Int; 1976 Nov; 10(5):409-22. PubMed ID: 1003730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist.
    Ifudu O; Dawood M; Homel P; Friedman EA
    Am J Kidney Dis; 1996 Dec; 28(6):841-5. PubMed ID: 8957035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorbent membrane dialysis in uremia.
    Randerson DH; Gurland HJ; Schmidt B; Farrell PC; Hone PW; Stokoe C; Zuber A; Blogg A; Fateh-Moghadam A; Marschner I; Köpcke W
    Contrib Nephrol; 1982; 29():53-64. PubMed ID: 7075216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodialysis and the elderly patient: potential advantages as to quality of life, urea generation, serum creatinine, and less interdialytic weight gain.
    Avram MR; Pena C; Burrell D; Antignani A; Avram MM
    Am J Kidney Dis; 1990 Oct; 16(4):342-5. PubMed ID: 2220783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications and outcome of hemodialysis in cats: a review of 29 cases.
    Langston CE; Cowgill LD; Spano JA
    J Vet Intern Med; 1997; 11(6):348-55. PubMed ID: 9470160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assay of serum abnormalities in uremic and dialysis patients. Evidence for depletion of vital substances in hemodialysis.
    Quadracci LJ; Cambi V; Christopher TG; Harker LA; Striker GE
    Trans Am Soc Artif Intern Organs; 1971; 17():96-101. PubMed ID: 5158140
    [No Abstract]   [Full Text] [Related]  

  • 7. Phosphate mass removal during hemodialysis: a comparison between eKT/V-matched conventional and extended dialysis.
    Sampaio MS; Ruzany F; Dorigo DM; Suassuna JH
    Am J Nephrol; 2012; 36(2):121-6. PubMed ID: 22776782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems and solutions for artificial kidney.
    Vanholder R
    Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of end-stage renal disease and dialysis modalities on blood ammonia level.
    Vaziri ND; Khazaeli M; Nunes ACF; Harley KT; Said H; Alipour O; Lau WL; Pahl MV
    Hemodial Int; 2017 Jul; 21(3):343-347. PubMed ID: 27804262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hemofiltration. A critical evaluation of a new method for the treatment of blood.
    Schaefer K; von Herrath D; Gullberg CA; Asmus G; Hüfler M; Offermann G; Cremer H; Heuck CC; Ritz E
    Artif Organs; 1978 Nov; 2(4):386-94. PubMed ID: 743012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein in the diets of dialyzed and non-dialyzed uremic patients. Study with nitrogen-labeled urea.
    Smith EB; Hill PA
    J Am Diet Assoc; 1972 May; 60(5):389-93. PubMed ID: 5018368
    [No Abstract]   [Full Text] [Related]  

  • 13. Physiologic studies in normal and uremic sheep: I. The experimental model.
    Eschbach JW; Adamson JW; Dennis MB
    Kidney Int; 1980 Dec; 18(6):725-31. PubMed ID: 7206457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
    Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
    Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Middle molecule accumulation in uremia: an "extra uremic factor".
    Oulès R; Emond C; Claret G; Branger B; Mion H; Mion C
    Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients?
    Friga V; Linos A; Linos DA
    Nephron; 1997; 75(1):48-53. PubMed ID: 9031270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.
    Basile C; Libutti P; Di Turo AL; Casino FG; Vernaglione L; Tundo S; Maselli P; De Nicolò EV; Ceci E; Teutonico A; Lomonte C
    Nephrol Dial Transplant; 2011 Apr; 26(4):1296-303. PubMed ID: 20813765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined hemodialysis-hemoperfusion treatment reduces the time of substitutive therapy in chronic uremia.
    Stefoni S; Feliciangeli G; Coli L; Scolari MP; Bonomini V
    Int J Artif Organs; 1981 Jul; 4(4):186-91. PubMed ID: 7327760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uremic neuropathy: evidence of middle molecule toxicity.
    Milutinovic J; Babb AL; Eschbach JW; Follette WC; Graefe U; Strand MJ; Scribner BH
    Artif Organs; 1978 Feb; 2(1):45-51. PubMed ID: 687020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative evaluation of dialysis treatment. The priority of urea kinetic modelling].
    Simeonov P
    Vutr Boles; 1984; 23(2):7-12. PubMed ID: 6377704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.